Purification and reconstitution of calcium channel drug-receptor sites.
Glossmann
H
H
Institute of Biochemical Pharmacology, University of Innsbruck, Austria.
Striessnig
J
J
Hymel
L
L
Schindler
H
H
D000345:Affinity Labels; D000818:Animals; D001386:Azides / Q000378:metabolism; D002118:Calcium / Q000378:metabolism*; D015220:Calcium Channels; D004095:Dihydropyridines / Q000378:metabolism; D006168:Guinea Pigs; D007473:Ion Channels / Q000032:analysis* / Q000502:physiology; D009132:Muscles / Q000032:analysis; D011955:Receptors, Drug / Q000302:isolation & purification*; D011978:Receptors, Nicotinic / Q000302:isolation & purification*; D014700:Verapamil / Q000031:analogs & derivatives* / Q000378:metabolism
D000345:Affinity Labels; D001386:Azides; D015220:Calcium Channels; D004095:Dihydropyridines; D007473:Ion Channels; D011955:Receptors, Drug; D011978:Receptors, Nicotinic; C041130:azidopine; C043184:4-desmethoxyverapamil; D014700:Verapamil; D002118:Calcium